Effect of retatrutide on kidney parameters in people with type 2 diabetes and/or obesity: a post-hoc analysis of two phase 2 trials

被引：0
|
作者：
Heerspink, H. [1 ]
Lu, Z. [2 ]
Du, Y. [2 ]
Duffin, K. [2 ]
Coskun, T. [2 ]
Haupt, A. [2 ]
Hartman, M. L. [2 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] Eli Lilly & Co, Indianapolis, IN USA
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
743
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [21] Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
    Oshima, Megumi
    Neuen, Brendon L.
    Jardine, Meg J.
    Bakris, George
    Edwards, Robert
    Levin, Adeera
    Mahaffey, Kenneth W.
    Neal, Bruce
    Pollock, Carol
    Rosenthal, Norman
    Wada, Takashi
    Wheeler, David C.
    Perkovic, Vlado
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11): : 903 - 914
  • [22] EFFECT OF STEM CELL INFUSION THERAPY ON SEXUAL FUNCTION IN WOMEN WITH TYPE 2 DIABETES AND METABOLIC SYNDROME: POST-HOC ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Saltzman, R.
    Ripps, S.
    Balaji, N.
    Cabreja, M.
    Schulman, I
    Khan, A.
    Golan, R.
    Hare, J.
    Ramasamy, R.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (08): : S31 - S31
  • [23] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [24] SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. G.
    Leiter, L. A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
  • [25] Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
    Waldman, Boris
    Ansquer, Jean-Claude
    Sullivan, David R.
    Jenkins, Alicia J.
    McGill, Neil
    Buizen, Luke
    Davis, Timothy M. E.
    Best, James D.
    Li, Liping
    Feher, Michael D.
    Foucher, Christelle
    Kesaniemi, Y. Antero
    Flack, Jeffrey
    d'Emden, Michael C.
    Scott, Russell S.
    Hedley, John
    Gebski, Val
    Keech, Anthony C.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (04): : 310 - 318
  • [26] EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON
    Rossing, Peter
    Block, Geoffrey
    Chertow, Glenn
    Chin, Melanie
    Goldsberry, Angie
    McCullough, Peter
    Meyer, Colin
    Packham, David
    Spinowitz, Bruce
    Sprague, Stuart
    Warnock, David
    Pergola, Pablo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [27] Reductions in liver enzymes are associated with anti-hyperglycaemic and anti-obesity effects of tofogliflozin in people with type 2 diabetes: Post-hoc analyses
    Takamura, Toshinari
    Kaku, Kohei
    Yoshida, Akihiro
    Kusakabe, Hiromi
    Nakamura, Hiroyuki
    Suganami, Hideki
    ENDOCRINOLOGY DIABETES & METABOLISM, 2024, 7 (01)
  • [28] Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes
    Ferreira, Joao Pedro
    Sharma, Abhinav
    Vasques-Novoa, Francisco
    Angelico-Goncalves, Antonio
    Leite, Ana Rita
    Borges-Canha, Marta
    Carvalho, Davide
    Packer, Milton
    Zannad, Faiez
    Leite-Moreira, Adelino
    Neves, Joao Sergio
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1792 - 1801
  • [29] Lixisenatide and Renal Outcomes in Patients with Type 2 Diabetes-A Post-Hoc Analysis of the ELIXA Trial
    Muskiet, Marcel A.
    Tonneijck, Lennart
    Huang, Yao
    Liu, Minzhi
    Saremi, Aramesh
    Heerspink, Hiddo Lambers.
    Van Raalte, Daniel H.
    DIABETES, 2018, 67
  • [30] Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial
    Curovic, Viktor Rotbain
    Tofte, Nete
    Lindhardt, Morten
    Adamova, Katarina
    Bakker, Stephan J. L.
    Beige, Joachim
    Beulens, Joline W. J.
    Birkenfeld, Andreas L.
    Currie, Gemma
    Delles, Christian
    Dimos, Ingo
    Francova, Lidmila
    Frimodt-Moller, Marie
    Girman, Peter
    Goeke, Ruediger
    Hansen, Tine W.
    Havrdova, Tereza
    Kooy, Adriaan
    Laverman, Gozewijnw D.
    Mischak, Harald
    Navis, Gerjan
    Nijpels, Giel
    Noutsou, Marina
    Ortiz, Alberto
    Parvanova, Aneliya
    Persson, Frederik
    Petrie, John R.
    Ruggenenti, Piero L.
    Rutters, Femke
    Rychlik, Ivan
    Siwy, Justyna
    Spasovski, Goce
    Speeckaert, Marijn
    Trillini, Matias
    Zuerbig, Petra
    von der Leyen, Heiko
    Rossing, Peter
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (04)
12345